本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Amylyx Pharmaceuticals

15.29
+0.12000.79%
成交量:104.21萬
成交額:1,558.00萬
市值:16.79億
市盈率:-8.62
高:15.48
開:15.00
低:14.43
收:15.17
52周最高:17.49
52周最低:2.60
股本:1.10億
流通股本:6,544.94萬
量比:1.62
換手率:1.59%
股息:- -
股息率:- -
每股收益(TTM):-1.7742
每股收益(LYR):-4.4281
淨資產收益率:-56.52%
總資產收益率:-39.44%
市淨率:5.06
市盈率(LYR):-3.45

資料載入中...

2026/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/08

重要事件披露

Form 8-K - Current report
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/09/10

重要事件披露

Form 8-K - Current report
2025/08/27

重要事件披露

Form 8-K - Current report
2025/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]